Antibody Persistence, and Safety and Tolerability of a Booster Dose of the Meningococcal B Vaccine After the Completion of the Vaccination Course in Study V72_28

Clinical trial NCT01894919 · COMPLETED

Trial details

NCT number: NCT01894919
Sponsor: Novartis Vaccines
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Meningoccocal Disease Meningococcal Meningitis

Start date: 2013-06-01
Primary completion: 2015-09-01
Enrollment: 851

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.